Clinical trials
Terminated trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
655 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 9 |
| 2004 | 6 |
| 2005 | 18 |
| 2006 | 25 |
| 2007 | 25 |
| 2008 | 34 |
| 2009 | 29 |
| 2010 | 33 |
| 2011 | 36 |
| 2012 | 24 |
| 2013 | 30 |
| 2014 | 27 |
| 2015 | 27 |
| 2016 | 14 |
| 2017 | 30 |
| 2018 | 42 |
| 2019 | 37 |
| 2020 | 58 |
| 2021 | 67 |
| 2022 | 42 |
| 2023 | 26 |
| 2024 | 10 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 655 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 40 |
| Hoffmann-La Roche | 30 |
| Pfizer | 27 |
| Sanofi | 25 |
| AstraZeneca | 22 |
| University of Sao Paulo | 22 |
| Janssen Research & Development, LLC | 17 |
| Bristol-Myers Squibb | 15 |
| Eli Lilly and Company | 12 |
| Merck Sharp & Dohme LLC | 12 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 44 |
| Carcinoma, Non-Small-Cell Lung | 23 |
| Breast Neoplasms | 19 |
| Diabetes Mellitus, Type 2 | 16 |
| Cardiovascular Diseases | 13 |
| Lupus Erythematosus, Systemic | 12 |
| Stroke | 12 |
| Diabetes Mellitus | 11 |
| Neoplasms | 11 |
| Pulmonary Arterial Hypertension | 11 |
Trials
Showing 51 to 75 of 655. Each trial links to its page on Pharma Observatory.
555 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.